EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance

Xinxing Wang, Wei Su, Chuan Qin, Ruxin Gao, Shuai Shao, Xianwen Xu, Zhenhai Zhang, Junlin Gao

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2907269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Xinxing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China. Hauptthemen laut MEDLINE: Gemcitabine, Deoxycytidine, Drug Resistance, Neoplasm, Pancreatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province, Foundation research project of Qinghai province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The TGF-β gene is a gemcitabine (GEM) resistance gene; however, the mechanism by which it regulates GEM resistance in pancreatic cancer remains unclear.

Methods

The PANC-1 cell line was treated with GEM and then stimulated with TGF-β. Subsequently, we constructed GEM-resistant pancreatic cancer cell lines, knocked down TGF-β in these cell lines, and detected changes in the proliferation and apoptosis of drug-resistant cancer cells. In addition, the protein expression levels of KLF-4, GFI-1, and ZEB-1 were determined. The xenograft tumor models of nude mice were constructed by subcutaneously injecting GEM-resistant PANC-1 cells into mouse axilla. The tumors were removed, dissected, and weighed after 6 weeks. The protein levels of KLF-4, GFI-1, and ZEB-1 in tumor tissues were quantified. In addition, the percentage of M2 macrophages in tumor tissues was determined using flow cytometry.

Results

The protein levels of TGF-β in pancreatic cancer cells were significantly decreased after GEM treatment. The protein expression of KLF-4 was downregulated, whereas the expressions of GFI-1 and ZEB-1 were upregulated after TGF-β stimulation. Apoptosis increased and proliferation decreased after TGF-β knockdown in GEM-resistant pancreatic cancer cells, moreover, silencing TGF-β promoted the expression of Caspase 3 and Cleaved caspase 3. In addition, the protein expression of KLF-4 was upregulated, whereas the expressions of GFI-1 and ZEB-1 were downregulated. Further, the volume and weight of the transplanted tumor decreased after TGF-β knockdown. The protein expression of KLF-4 was upregulated, whereas the expressions of GFI-1 and ZEB-1 were downregulated in tumor tissues. In addition, the percentage of M2 macrophages decreased in tumor tissues after TGF-β knockdown.

Conclusions

The knockdown of TGF-β inhibits epithelial-to-mesenchymal transition, suppresses the proliferation and promotes the apoptosis of drug-resistant cancer cells, and decreases the macrophage polarization to the M2 phenotype, consequently ameliorating GEM resistance in pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GemcitabineDeoxycytidineDrug Resistance, NeoplasmPancreatic NeoplasmsTransforming Growth Factor betaMice, NudeApoptosisKruppel-Like Factor 4Antimetabolites, AntineoplasticCell ProliferationZinc Finger E-box-Binding Homeobox 1Gene Knockdown TechniquesAnimalsHumansCell Line, TumorMiceKruppel-Like Transcription FactorsDNA-Binding ProteinsXenograft Model Antitumor AssaysTranscription Factors

Stichwörter der Autor:innen

EMTM2-type polarizationTGF-βgemcitabine resistancepancreatic cancer

Substanzen

GemcitabineDeoxycytidineTransforming Growth Factor betaKruppel-Like Factor 4Antimetabolites, AntineoplasticZinc Finger E-box-Binding Homeobox 1Klf4 protein, mouseKLF4 protein, humanKruppel-Like Transcription FactorsDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China.
  • Liver Gall Bladder and Pancreatic Surgery Ward, Qinghai Red Cross Hospital, 810001 Xining, Qinghai, China.

Förderung

  • Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province
  • Foundation research project of Qinghai province

Zitieren

APA

Wang, X., Su, W., Qin, C., Gao, R., Shao, S., Xu, X., Zhang, Z., & Gao, J. (2024). Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907269

Vancouver

Wang X, Su W, Qin C, Gao R, Shao S, Xu X, et al. Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907269

BibTeX
@article{Wang2024,
  author = {Wang, Xinxing and Su, Wei and Qin, Chuan and Gao, Ruxin and Shao, Shuai and Xu, Xianwen and Zhang, Zhenhai and Gao, Junlin},
  title = {Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2907269}
}
Kostenlos starten →